COMPOSITION AND METHOD FOR CONTROL OF INFECTIOUS DISEASES WITH FUNCTIONAL FLAVORING SUBSTANCES Russian patent published in 2023 - IPC A61K31/15 A61K31/45 A61K31/85 A61K31/11 A61K31/35 A61P31/00 A61P31/16 

FIELD: pharmaceutical industry.

SUBSTANCE: group of inventions relates to the pharmaceutical industry, namely to a composition for inhibition of E. coli infection, methicillin-resistant staphylococcus aureus (hereinafter – MRSA), influenza virus, rhinovirus, or M. Tuberculosis. Composition (1) for inhibition of E. coli infection, MRSA, influenza virus, rhinovirus, or M. Tuberculosis contains: 0.25-7% of β-pinene, 0.25-25% of borneol, 5-30% of cinnamon aldehyde, 0.25-25% of citral, 0.25-5% of d-limonene, 1-10% of eucalyptol, 1-15% of eugenol, 10-30% of farnesol, 25-50% of linalool, 0.5-7% of thymol, and 2.7% of vanillin. Composition (2) for inhibition of E. coli infection, MRSA, influenza virus, rhinovirus, or M. Tuberculosis contains: 1-3% of β-pinene, 1-5% of borneol, 15-25% of cinnamon aldehyde, 1-3% of d-limonene, 5-10% of eucalyptol, 5-15% of eugenol, 25-50% of linalool, 0.5-2% of thymol, and 5-10% of vanillin. A method for inhibition of E. coli infection, MRSA, influenza virus, rhinovirus, or M. Tuberculosis includes administration of therapeutically effective amount of above-described composition (1) to a patient who needs it. A method for inhibition of E. coli infection, MRSA, influenza virus, rhinovirus, or M. Tuberculosis includes administration of therapeutically effective amount of above-described composition (2) to a patient who needs it.

EFFECT: above-described compositions and methods are effective for inhibition of E. coli infection, MRSA, influenza virus, rhinovirus, or M. Tuberculosis.

16 cl, 13 ex